Liver function discovery could revolutionize treatments for cardiovascular disease

Dai­ichi Sankyo is ready to de­fend it­self in court af­ter Asia’s largest pri­vate health­care group filed a law­suit al­leg­ing that Dai­ichi un­law­ful­ly in­ter­fered with its

An­oth­er 500 jobs are on the chop­ping block as a re­sult of Pfiz­er’s cost-cut­ting mea­sures, this time at the com­pa­ny’s site in Sand­wich, UK, where

The Eu­ro­pean Med­i­cines Agency said this week that it’s look­ing in­to da­ta — ret­ro­spec­tive ob­ser­va­tion­al da­ta that need to be cor­rect­ed by the com­pa­ny that